JPH08508271A - Ｅａａ拮抗体としてのイミダゾロキノキサリノン誘導体 - Google Patents

Ｅａａ拮抗体としてのイミダゾロキノキサリノン誘導体

Info

Publication number
JPH08508271A
JPH08508271A JP6521617A JP52161794A JPH08508271A JP H08508271 A JPH08508271 A JP H08508271A JP 6521617 A JP6521617 A JP 6521617A JP 52161794 A JP52161794 A JP 52161794A JP H08508271 A JPH08508271 A JP H08508271A
Authority
JP
Japan
Prior art keywords
dihydro
quinoxaline
group
imidazolo
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6521617A
Other languages
English (en)
Japanese (ja)
Inventor
トライバー，ハンス−イエルク
ベール，ベルトルト
ペーター ホーフマン，ハンス
Original Assignee
ビーエーエスエフ アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4329970A external-priority patent/DE4329970A1/de
Application filed by ビーエーエスエフ アクチエンゲゼルシャフト filed Critical ビーエーエスエフ アクチエンゲゼルシャフト
Publication of JPH08508271A publication Critical patent/JPH08508271A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP6521617A 1993-03-31 1994-03-19 Ｅａａ拮抗体としてのイミダゾロキノキサリノン誘導体 Pending JPH08508271A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4310521 1993-03-31
DE4329970A DE4329970A1 (de) 1993-03-31 1993-09-04 Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
DE4310521.1 1993-09-04
DE4329970.9 1993-09-04
PCT/EP1994/000871 WO1994022865A1 (de) 1993-03-31 1994-03-19 Imidazolochinoxalinonderivate als eaa antagonisten

Publications (1)

Publication Number Publication Date
JPH08508271A true JPH08508271A (ja) 1996-09-03

Family

ID=25924528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6521617A Pending JPH08508271A (ja) 1993-03-31 1994-03-19 Ｅａａ拮抗体としてのイミダゾロキノキサリノン誘導体

Country Status (17)

Country Link
EP (1) EP0691970B1 (hu)
JP (1) JPH08508271A (hu)
CN (1) CN1041928C (hu)
AT (1) ATE173263T1 (hu)
AU (1) AU6428294A (hu)
BR (1) BR9406034A (hu)
CA (1) CA2158167A1 (hu)
CZ (1) CZ246495A3 (hu)
FI (1) FI954614A (hu)
HR (1) HRP940210A2 (hu)
HU (1) HUT73970A (hu)
IL (1) IL109076A (hu)
NO (1) NO953892D0 (hu)
NZ (1) NZ263552A (hu)
PL (1) PL310950A1 (hu)
SI (1) SI9420023A (hu)
WO (1) WO1994022865A1 (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021842A1 (en) * 1994-02-11 1995-08-17 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
FR2722789B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
IT1276167B1 (it) * 1995-11-24 1997-10-27 Foscama Biomed Chim Farma Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
GB0017518D0 (en) * 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0018473D0 (en) * 2000-07-27 2000-09-13 Merck Sharp & Dohme Therapeutic agents
CN100386326C (zh) * 2003-10-22 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 1-羟甲基咪唑并[1，2-a]喹喔啉化合物及其应用
FR2921927B1 (fr) * 2007-10-03 2012-10-12 Univ De Montpellier 1 Imidazo°1,2-a!quinoxalines et derives pour le traitement des cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
JP5578786B2 (ja) * 2006-12-13 2014-08-27 あすか製薬株式会社 キノキサリン誘導体

Also Published As

Publication number Publication date
PL310950A1 (en) 1996-01-08
IL109076A0 (en) 1994-06-24
SI9420023A (en) 1996-04-30
FI954614A0 (fi) 1995-09-28
NZ263552A (en) 1997-06-24
AU6428294A (en) 1994-10-24
FI954614A (fi) 1995-09-28
WO1994022865A1 (de) 1994-10-13
HRP940210A2 (en) 1996-12-31
ATE173263T1 (de) 1998-11-15
CN1120336A (zh) 1996-04-10
BR9406034A (pt) 1996-01-02
CZ246495A3 (en) 1996-03-13
NO953892L (no) 1995-09-29
IL109076A (en) 1997-06-10
EP0691970B1 (de) 1998-11-11
HU9502848D0 (en) 1995-11-28
HUT73970A (en) 1996-10-28
CN1041928C (zh) 1999-02-03
NO953892D0 (no) 1995-09-29
CA2158167A1 (en) 1994-10-13
EP0691970A1 (de) 1996-01-17

Similar Documents

Publication Publication Date Title
CA2138026C (en) Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists
AU638096B2 (en) Novel benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present
JP2550456B2 (ja) 縮合ピラジン誘導体
US5128359A (en) Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
JP3212758B2 (ja) キノキサリン−２，３−（１ｈ，４ｈ）−ジオン
HUT60465A (en) Process for producing carboxylic acid amides and pharmaceutical compositions comprising such active ingredient
JP2002510687A (ja) アミノアルキル置換ピロロ［２，３−ｂ］ピリジンおよびピロロ［２，３−ｄ］ピリミジン誘導体：ｃｒｆ１レセプタのモジュレータ
NZ265599A (en) Quinoxalindione derivatives, preparation and pharmaceutical compositions thereof
JPH08508271A (ja) Ｅａａ拮抗体としてのイミダゾロキノキサリノン誘導体
JPH05505810A (ja) キノキサリン化合物並びにその製造及び使用
US5597922A (en) Glycine receptor antagonist pharmacophore
AU2014267225A1 (en) Perhydroquinoxaline derivatives useful as analgesics
JP2000505793A (ja) ２，３―ベンゾジアゼピン誘導体及びそのａｍｐａ―レセプター抑制剤としての使用
JPH07501791A (ja) トリアゾロキノキサリン−１，４−ジオンならびにその製造方法および用途
JPH0699430B2 (ja) 活性化合物，その製造方法及びそれを含む医薬組成物
KR100304177B1 (ko) (1,2,4)트리아졸로(4,3-a)퀴녹살린화합물,이의제조방법및이를함유하는약제학적조성물_
US8268854B2 (en) Aza-beta-carbolines and methods of using same
US6277850B1 (en) Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists
US6121265A (en) Heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
CA2326319A1 (en) Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
JPH10509131A (ja) 新規キノキサリンおよび該キノキサリンからなる医薬品
JPH10501801A (ja) 新規のアミド−キノキサリンジオン、その製造及び使用
JP2000515528A (ja) ピロロ（３，２―ｃ）キノリン誘導体
TW492969B (en) 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, their preparation and the medicaments containing them
JP3490445B2 (ja) 新規トリアゾロピリミドン、その製造および使用